Investigator

Sridhar Rao

Interim Co-Director · Versiti Blood Center of Wisconsin, Versiti Blood Research Institute

Research Interests

SRSridhar Rao
Papers(1)
The miR-23a∼27a∼24-2 …
Collaborators(4)
Jennifer SkibbeKaren D Cowden DahlKirthi PulakantiRichard Dahl
Institutions(3)
Blood Systems Researc…Mike And Josie Harper…University Of Notre D…

Papers

The miR-23a∼27a∼24-2 microRNA Cluster Promotes Inflammatory Polarization of Macrophages

Abstract Macrophages are critical for regulating inflammatory responses. Environmental signals polarize macrophages to either a proinflammatory (M1) state or an anti-inflammatory (M2) state. We observed that the microRNA (miRNA) cluster mirn23a, coding for miRs-23a, -27a, and -24-2, regulates mouse macrophage polarization. Gene expression analysis of mirn23a-deficient myeloid progenitors revealed a decrease in TLR and IFN signaling. Mirn23a−/− bone marrow–derived macrophages (BMDMs) have an attenuated response to LPS, demonstrating an anti-inflammatory phenotype in mature cells. In vitro, mirn23a−/− BMDMs have decreased M1 responses and an enhanced M2 responses. Overexpression of mirn23a has the opposite effect, enhancing M1 and inhibiting M2 gene expression. Interestingly, expression of mirn23a miRNAs goes down with inflammatory stimulation and up with anti-inflammatory stimulation, suggesting that its regulation prevents locking macrophages into polarized states. M2 polarization of tumor-associated macrophages (TAMs) correlates with poor outcome for many tumors, so to determine if there was a functional consequence of mirn23a loss modulating immune cell polarization, we assayed syngeneic tumor growth in wild-type and mirn23a−/− mice. Consistent with the increased anti-inflammatory/immunosuppressive phenotype in vitro, mirn23a−/− mice inoculated with syngeneic tumor cells had worse outcomes compared with wild-type mice. Coinjecting tumor cells with mirn23a−/− BMDMs into wild-type mice phenocopied tumor growth in mirn23a−/− mice, supporting a critical role for mirn23a miRNAs in macrophage-mediated tumor immunity. Our data demonstrate that mirn23a regulates M1/M2 polarization and suggests that manipulation of mirn23a miRNA can be used to direct macrophage polarization to drive a desired immune response.

1Works
1Papers
4Collaborators
Leukemia, Myeloid, AcuteCell Line, TumorTumor MicroenvironmentMyelodysplastic SyndromesMyeloproliferative DisordersImmunologic Deficiency SyndromesNeoplasms, ExperimentalOvarian Neoplasms

Positions

2025–

Interim Co-Director

Versiti Blood Center of Wisconsin · Versiti Blood Research Institute

2023–

Hematopoiesis and Immunology Program Co-Leader

Versiti Blood Center of Wisconsin · Versiti Blood Research Institute

2010–

Senior Investigator

Versiti · Versiti Blood Research Institute

Education

2001

MD

University of Chicago · Pritzker School of Medicine

1999

PhD

University of Chicago · Pathology

1994

B.Ch.E

University of Minnesota, Twin Cities · Chemical Engineering

Country

US

Keywords
Acute Myeloid LeukemiaMultiple MyelomaHypertensionEpigeneticsGene Expression
Links & IDs